Skip to content

Repligen

US · RGEN #1445 by market cap Listed 1970
163.81 -6.48 -3.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Valuation each multiple against its own 5-year range

P/B ratio 5.13 Expensive vs history 73rd percentile
5-year average 4.69 · #37 of 51 in Medical Instruments & Supplies
P/E ratio -799.00 Cheap vs history 12th percentile
5-year average 111.31 · forward 155.00 · #24 of 27 in Medical Instruments & Supplies
P/S ratio 13.31 In line with history 65th percentile
5-year average 13.05 · forward 10.45 · #44 of 51 in Medical Instruments & Supplies

Vs. peers Medical Instruments & Supplies

Company Market cap P/E (TTM) P/B Div yield
Repligen (RGEN) 10.47B -780.05 5.01 0.00%
Intuitive Surgical (ISRG) 138.33B 48.25 8.65 0.00%
Becton Dickinson & Co (BDX) 57.96B 52.02 2.35 1.97%
Alcon (ALC) 35.92B 54.24 1.64 0.48%
ResMed (RMD) 33.14B 21.46 5.57 1.04%
Medline (MDLN) 32.55B 57.52 2.76 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value171.55 Economic moatNarrow UncertaintyLow

Trading 4.7% below Morningstar's fair value estimate.

Fair value

Repligen Corp is assigned a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 2% discount to our quantitative fair value estimate of $171.55 per share, which is reinforced by this estimate's low uncertainty rating.

We need more explanatory data to elaborate on this stock's star rating. We strive to explain the factors driving every rating we assign; however, this is not yet possible for a small fraction of our coverage universe.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Repligen discussion 0 comments

Add a comment